Submission Details

Submitter:

Classification:
Limited
GENCC:100004
Gene:
Disease:
congenital heart disease
Mode Of Inheritance:
Autosomal dominant
Evaluated Date:
08/14/2023
Evidence/Notes:

ADAM17 (formerly known as TACE) was FIRST reported in relation to autosomal dominant congenital heart disease in 2016 (Priest et al., PMID: 27058611). For this curation, variants in ADAM17 have been reported in individuals with the following phenotypes: Tetralogy of Fallot and atrioventricular septal defect. Of note, this gene has also been implicated in neonatal inflammatory skin and bowel disease (OMIM:614328). This will be assessed separately. At least six unique missense variants have been reported in humans with congenital heart disease; however, three of them were too frequent to cause disease. Evidence supporting this gene-disease relationship includes case-level data. Variants in this gene have been reported in at least five probands in two publications (PMIDs: 27058611, 30610007). This gene-disease relationship is supported by animal models and expression studies (PMIDs: 9812885, 12773386, 14499647, 15936750, 33957124). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date 08/14/2023 (SOP Version 9).

PubMed IDs:
9812885 27058611 30610007 33957124
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.